Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study
-
* Corresponding author: Alexandros Ardavanis alardavanis@yahoo.com
BMC Cancer 2009, 9:338 doi:10.1186/1471-2407-9-338
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 10 Dec 2008 | |
| Reviewer's Report | Paolo Bruzzi | 19 Jan 2009 | |
| Reviewer's Report | Bhawna Sirohi | 12 Feb 2009 | |
| Resubmission - Version 2 | Manuscript | 13 Apr 2009 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 13 Apr 2009 |
| Resubmission - Version 4 | Manuscript | Author's comment | 13 Apr 2009 |
| Reviewer's Report | Paolo Bruzzi | 28 Apr 2009 | |
| Reviewer's Report | Bhawna Sirohi | 30 Apr 2009 | |
| Resubmission - Version 5 | Manuscript | Author's comment | 06 Jul 2009 |
| Reviewer's Report | Paolo Bruzzi | 20 Aug 2009 | |
| Resubmission - Version 6 | Manuscript | Author's comment | 26 Aug 2009 |
| Editorial acceptance | 17 Sep 2009 | ||
| Published | 23 Sep 2009 |